At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 181 enrolled
Drug / intervention
chloroquine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of Glucose-6-dehydrogenase Status in South-east Bangladesh
In Brief
A Phase 4 clinical trial evaluating chloroquine, Artemether-lumefantrine combination, and 1 other intervention for Malaria. Completed, enrolled 181 participants.
Detailed Summary
This is a study assessing safety and efficacy of current national guidelines for the treatment of uncomplicated malaria in Bangladesh as well as to assess the G6PD status among the enrolled patients.
Study Details
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
Primary CompletionMar 2015
First PostedMar 2015
TodayJul 2026
First PostedMar 17, 2015
Enrollment StartAug 1, 2014
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.3 years ago
Interventions
chloroquinedrug
standard dose
Artemether-lumefantrine combinationdrug
standard dose
Primaquinedrug
single dose
Primaquinedrug
14 days